FDA Approves First Oral UTI Antibiotic in Decades for Women

Gepotidacin offers a new treatment path for uncomplicated UTIs, targeting common resistant bacteria in girls and women

Topline:

The FDA has approved gepotidacin (Blujepa), a first-in-class oral antibiotic for uncomplicated urinary tract infections in women and girls aged 12 and older, offering a novel mechanism of action and a promising alternative to traditional therapies like nitrofurantoin.

Study Details

Gepotidacin, developed by GSK, is a pioneering antibiotic that inh…